Cibus Inc (CBUS) USD0.0001 A

Sell:$2.14Buy:$2.15$0.20 (8.51%)

Prices delayed by at least 15 minutes
Sell:$2.14
Buy:$2.15
Change:$0.20 (8.51%)
Prices delayed by at least 15 minutes
Sell:$2.14
Buy:$2.15
Change:$0.20 (8.51%)
Prices delayed by at least 15 minutes

Company Information

About this company

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Key people

Rory B. Riggs
Chairman of the Board, Co-Founder
Peter Ronald Beetham
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
Greg Gocal
Co-Founder, Executive Vice President, Chief Scientific Officer
Cornelis Broos
Interim Chief Financial Officer
Noel Sauer
Senior Vice President - Research
Jason Stokes
Chief Legal Officer, General Counsel and Corporate Secretary
Mark Finn
Lead Independent Director
Jean-Pierre Lehmann
Independent Director
August J. Moretti
Independent Director
Gerhard Prante
Independent Director
Keith A. Walker
Independent Director
Click to see more

Key facts

  • EPIC
    CBUS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US17166A1016
  • Market cap
    $85.88m
  • Employees
    157
  • Shares in issue
    32.68m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.